AHCC06 Result Presentation

AHCC06 Phase III Multi-Centre Open-Label Randomized Controlled Trial of Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (NCT01135056)

Final Analysis Result Presentation at 2017 ASCO Annual Meeting

Chicago, 4 June 2017

The result of the final analysis of the AHCC06 will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on 4 June 2017 in Chicago. AHCC06 Principal Investigator, Prof Pierce Chow will be presenting the result for the 1^st time. The ASCO Annual Meeting is one of the largest educational and scientific events in the oncology community.